IRADIMED CORPORATION Reports Record Second Quarter 2025 Financial Results
1. IRMD reports record revenue of $20.4 million, a 14% increase YoY. 2. Quarterly GAAP EPS of $0.45, up 18% YoY, reflects financial growth. 3. A quarterly cash dividend of $0.17 per share announced for Q3 2025. 4. Operational efficiency may decline in Q3 due to new facility adjustments. 5. Guidance for full-year revenue raised to $80-$82.5 million for 2025.